skip to content

 

Computational approach to minimise off-target toxicity of CAR T-cell therapy targeting myeloma

2 May 2024

Multiple myeloma is a type of bone marrow cancer which impacts a type of white blood cell called plasma cells, which are essential for the production of antibodies. Myeloma remains incurable but a treatment called CAR-T cell therapy - a type of cancer immunotherapy - could be a promising new avenue for treatment, if...

Read more

Dr Ieuan Walker awarded the Kay Kendall Leukaemia Fund (KKLF) Junior Fellowship

14 December 2021

Dr Ieuan Walker is currently an academic clinical fellow and haematology registrar but will be joining us to study for a PhD in September 2022. Ieuan will be joining the Chapman group to study RNA binding proteins in Myeloma.

Read more

Welcome to our new group leaders

22 October 2019

The Unit is delighted to announce the appointment of three new group leaders: Mike Chapman, Ritwick Sawarkar and Kiran Patil. Mike Chapman Mike’s programme will focus on the toxicity of CAR-T cell therapy. The lab will be combining genomic and proteomic approaches with more traditional ‘wet lab’ techniques to dissect the...

Read more